GERN
GeronCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
GERN vs peer average
48/100
GERN vs. peer average (C vs. C)
Grade spread
A 1 · B 3 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ABUS is the first available peer comparator.
Similar-market-cap biopharma comparator; useful for small-cap biotech risk appetite, but direct operating overlap with Geron's hematology portfolio is not established.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
GERN
Geron
ABUS
Arbutus Biopharma
Grade
C
B
Momentum
87
68
Value
41
56
Sentiment
66
71
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ABUS
GERN / ABUS
Grade Position
In line
GERN vs. peer average (C vs. C)
48/100
Momentum
87
GERNValue
41
ABUSSentiment
66
ABUSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs GERN
ABUS is the first peer returned for this comparison set.